OSF Sacred Heart Medical Center – Urbana
812 N Logan, Danville, IL · Osfhealthcare · · NPI 1699288449
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Inject/treat eye socket CPT 67500 | not published | not published | $340.14 – $4,342.00 | 5 |
| Inject/treat eye socket CPT 67505 | not published | not published | $340.14 – $4,342.00 | 5 |
| Inject/treat eye socket CPT 67515 | not published | not published | $340.14 – $4,342.00 | 5 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $34.33 – $40.71 | 4 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $27.58 – $39.73 | 4 |
| Inj., emapalumab-lzsg, 1 mg HCPCS J9210 | not published | not published | $384.14 – $465.43 | 4 |
| Inj., emicizumab-kxwh 0.5 mg HCPCS J7170 | not published | not published | $55.64 – $63.42 | 4 |
| Inj epidural sgl cerv-thor without img CPT 62320 | $1,279.20 | $2,132.00 | $756.44 – $4,342.00 | 4 |
| Inj epidural sgl lumb-sacral without img CPT 62322 | $1,279.20 | $2,132.00 | $947.82 – $4,342.00 | 4 |
| Inj, erzofri, 1 mg HCPCS J2428 | not published | not published | $14.49 – $20.92 | 4 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $197.63 – $227.30 | 4 |
| Inj., evomela, 1 mg HCPCS J9246 | not published | not published | $19.43 – $22.57 | 4 |
| Inj, exagamglogene autotem HCPCS J3392 | not published | not published | $2,332,000.00 – $2,845,040.00 | 4 |
| Inj, factor x, (human), 1iu HCPCS J7175 | not published | not published | $9.95 – $11.63 | 4 |
| Inj, faricimab-svoa, 0.1mg HCPCS J2777 | not published | not published | $32.87 – $42.36 | 4 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | not published | not published | $21.93 – $25.41 | 4 |
| Inj fensolvi 0.25 mg HCPCS J1951 | not published | not published | $140.71 – $163.80 | 4 |
| Inj., fibryga, 1 mg HCPCS J7177 | not published | not published | $1.24 – $1.34 | 4 |
| Inj fluphenazine hcl 1.25 mg HCPCS J2679 | not published | not published | $8.72 – $8.72 | 1 |
| Inj, focinvez, 1mg HCPCS J1434 | not published | not published | $2.55 – $3.68 | 4 |
| Inj for ext venography CPT 36005 | $1,212.60 | $2,021.00 | $1,534.00 – $4,342.00 | 2 |
| Inj for mammo ductogram CPT 19030 | $368.40 | $614.00 | $1,534.00 – $4,342.00 | 2 |
| Inj, fosaprepitant (teva) HCPCS J1456 | not published | not published | $0.04 – $1.48 | 4 |
| Inj fosnetupitant, palonoset HCPCS J1454 | not published | not published | $524.18 – $772.11 | 4 |
| Inj, fulvestrant (fresenius) HCPCS J9394 | not published | not published | $4.05 – $27.65 | 4 |
| Inj, fulvestrant (teva) HCPCS J9393 | not published | not published | $41.67 – $56.38 | 4 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $120.98 – $142.09 | 4 |
| Inj glofitamab gxbm, 2.5 mg HCPCS J9286 | not published | not published | $2,840.68 – $3,382.82 | 4 |
| Inj glycopyrrolate fres kabi HCPCS J1598 | not published | not published | $2.03 – $2.03 | 1 |
| Inj, granisetron, xr, 0.1 mg HCPCS J1627 | not published | not published | $3.88 – $6.45 | 4 |
| Inj., guselkumab, 1 mg HCPCS J1628 | not published | not published | $67.81 – $85.92 | 4 |
| Inj, hemgenix, per tx dose HCPCS J1411 | not published | not published | $3,691,450.00 – $4,496,025.34 | 4 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $59.91 – $76.76 | 4 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $56.02 – $90.17 | 4 |
| Inj hrt cath w/s&i nonsel p-art angrp CPT 93568 | $3,033.60 | $5,056.00 | $4,342.00 – $4,342.00 | 1 |
| Inj hrt cath w/s&i sel hrt ang CPT 93563 | $803.40 | $1,339.00 | $4,342.00 – $4,342.00 | 1 |
| Inj hrt cath w/s&i sel hrt art CPT 93564 | not published | not published | $4,342.00 – $4,342.00 | 1 |
| Inj hrt cath w/s&i sel left vent CPT 93565 | $3,033.60 | $5,056.00 | $4,342.00 – $4,342.00 | 1 |
| Inj hrt cath w/s&i sel right vent CPT 93566 | $3,033.60 | $5,056.00 | $4,342.00 – $4,342.00 | 1 |
| Inj human fibrinogen con nos HCPCS J7178 | not published | not published | $1.52 – $1.81 | 4 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | not published | not published | $5.44 – $6.32 | 4 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $77.68 – $93.88 | 4 |
| Inj, idacio, 1 mg HCPCS Q5144 | not published | not published | $11.80 – $11.80 | 1 |
| Inj imip 4 cilas 4 releb 2mg HCPCS J0742 | not published | not published | $3.05 – $3.05 | 1 |
| Inj, immphentiv, 20 mcg HCPCS J2373 | not published | not published | $0.17 – $0.17 | 1 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $495.54 – $590.97 | 4 |
| Inj/inf neurolyt sbst spinal canal lesion 62282 CPT 62282 | not published | not published | $947.82 – $4,342.00 | 5 |
| Inj intralesional <= 7 lsn(s) CPT 11900 | not published | not published | $215.00 – $4,342.00 | 5 |
| Inj intralesional > 7 lsns CPT 11901 | not published | not published | $215.00 – $4,342.00 | 5 |
| Inj, invega hafyera/trinza HCPCS J2427 | not published | not published | $12.95 – $15.46 | 4 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $49.53 – $60.00 | 4 |
| Inj, ixinity, 1 i.u HCPCS J7213 | not published | not published | $1.97 – $2.34 | 4 |
| Inj. jivi 1 iu HCPCS J7208 | not published | not published | $2.66 – $2.99 | 4 |
| Inj, kovaltry, 1 i.u HCPCS J7211 | not published | not published | $1.56 – $1.82 | 4 |
| Inj, lanreotide, (cipla) 1mg HCPCS J1932 | not published | not published | $31.01 – $32.83 | 4 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.34 – $1.62 | 4 |
| Inj, lenacapavir, 1 mg HCPCS J1961 | not published | not published | $22.30 – $26.88 | 4 |
| Inj, levothyroxine, freskabi HCPCS J0651 | not published | not published | $6.96 – $7.81 | 4 |
| Inj, levothyroxine, hikma HCPCS J0652 | not published | not published | $6.27 – $6.27 | 1 |
| Inj, lovotibeglogene autotem HCPCS J3394 | not published | not published | $3,245,381.39 – $4,008,920.00 | 4 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $327.72 – $389.00 | 4 |
| Inj., lumoxiti, 0.01 mg HCPCS J9313 | not published | not published | $23.39 – $28.54 | 4 |
| Inj luxturna 1 billion vec g HCPCS J3398 | not published | not published | $3,070.09 – $3,838.44 | 4 |
| Inj lwr xtr fscl pln blk uni w/wo image CPT 64473 | not published | not published | $4,342.00 – $4,342.00 | 1 |
| Inj melpha hydroch nos 50 mg HCPCS J9245 | not published | not published | $120.67 – $191.66 | 4 |
| Inj melphalan (hepzato) 1 mg HCPCS J9248 | not published | not published | $795.00 – $944.04 | 4 |
| Inj., meropenem, vaborbactam HCPCS J2186 | not published | not published | $2.17 – $2.57 | 4 |
| Inj meropenem (wg crit care) HCPCS J2183 | not published | not published | $1.95 – $1.95 | 1 |
| Inj, mirikizumab-mrkz, 1 mg HCPCS J2267 | not published | not published | $42.09 – $58.04 | 4 |
| Inj mogamulizumab-kpkc, 1 mg HCPCS J9204 | not published | not published | $253.47 – $297.23 | 4 |
| Inj, motixafortide, 0.25 mg HCPCS J2277 | not published | not published | $26.48 – $30.77 | 4 |
| Inj multihance HCPCS A9577 | $7.80 | $13.00 | not published | 0 |
| Inj. naxitamab-gqgk, 1 mg HCPCS J9348 | not published | not published | $686.09 – $783.03 | 4 |
| Inj nephrosto/ureterogram w/img exstng access CPT 50431 | $2,664.00 | $4,440.00 | $747.24 – $4,342.00 | 4 |
| Inj, nithiodote, 3mg / 125mg HCPCS J0211 | not published | not published | $2.17 – $2.65 | 4 |
| Inj, nogapendekin pmln, 1mcg HCPCS J9028 | not published | not published | $94.60 – $115.39 | 4 |
| Inj non-compmd foam sclrsnt mlt trncl veins same leg CPT 36466 | not published | not published | $2,211.05 – $4,342.00 | 4 |
| Inj non-compmd foam sclrsnt sgl trncl vein CPT 36465 | not published | not published | $2,211.05 – $4,342.00 | 4 |
| Inj, nyposi 1 mcg HCPCS Q5148 | not published | not published | $0.66 – $1.05 | 4 |
| Inj ocrelizumab 1mg hya-ocsq HCPCS J2351 | not published | not published | $46.79 – $55.13 | 4 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $35.78 – $57.12 | 4 |
| Inj, oliceridine 0.1 mg HCPCS C9101 | not published | not published | $1.59 – $1.59 | 1 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $395.60 – $465.11 | 4 |
| Inj, omacetaxine mep, 0.01mg HCPCS J9262 | not published | not published | $9.14 – $9.14 | 1 |
| Inj., omadacycline, 1 mg HCPCS J0121 | not published | not published | $4.13 – $4.72 | 4 |
| Inj onase abepar-xioi treat HCPCS J3399 | not published | not published | $2,587,087.26 – $2,956,220.10 | 4 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $29.81 – $35.06 | 4 |
| Inj, palonosetron (posfrea) HCPCS J2468 | not published | not published | $55.29 – $73.09 | 4 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $73.83 – $85.92 | 4 |
| Inj, pasireotide long acting HCPCS J2502 | not published | not published | $596.30 – $642.87 | 4 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $100.90 – $120.83 | 4 |
| Inj, pedmark, 100 mg HCPCS J0208 | not published | not published | $95.45 – $116.39 | 4 |
| Inj, pegcetacoplan, 1mg HCPCS J2781 | not published | not published | $147.81 – $175.67 | 4 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $30.15 – $122.03 | 4 |
| Inj, pegulicianine, 1 mg HCPCS A9615 | not published | not published | $37.51 – $45.76 | 4 |
| Inj. pemetrexed, 10 mg HCPCS J9304 | not published | not published | $7.99 – $56.55 | 4 |
| Inj pemetrexed (accord) 10mg HCPCS J9296 | not published | not published | $9.66 – $11.88 | 4 |
| Inj, pemetrexed (avyxa) 10mg HCPCS J9292 | not published | not published | $82.02 – $99.27 | 4 |
| Inj pemetrexed ditromethamin HCPCS J9323 | not published | not published | $12.61 – $12.61 | 1 |
| Inj pemetrexed, hospira 10mg HCPCS J9294 | not published | not published | $4.71 – $5.30 | 4 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.